Brief exposure to methamphetamine (METH) and phencyclidine (PCP) during late development leads to long-term learning deficits in rats

Brain Research

Volumn 1266, Issue , 2009, Pages 72-86

  White, Ilsun M ^a   Minamoto, Takehiro ^a   Odell, Joseph R ^a   Mayhorn, Joseph ^a   White, Wesley ^a  

^a MOREHEAD STATE UNIVERSITY   (United States)

Author keywords

Developmental; Dopamine; Neurotoxicity; NMDA; Prefrontal; Reversal; Social interaction

Indexed keywords

METHAMPHETAMINE; PHENCYCLIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; LEARNING DISORDER; LOCOMOTION; MALE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SOCIAL INTERACTION; SPATIAL DISCRIMINATION;

AGING; ANALYSIS OF VARIANCE; ANIMALS; CONDITIONING, OPERANT; LEARNING; LEARNING DISORDERS; MALE; METHAMPHETAMINE; MOTOR ACTIVITY; PHENCYCLIDINE; RATS; RATS, WISTAR; SOCIAL BEHAVIOR; SPATIAL BEHAVIOR;

RATTUS; RATTUS NORVEGICUS;

EID: 63449093155     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2009.02.024     Document Type: Article

References (77)

1. Adams B., and Moghaddam B. Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine. J. Neurosci. 18 (1998) 5545-5554
2. Amano T., Matsubayashi H., and Sasa M. Hypersensitivity of nucleus accumbens neurons to methamphetamine and DA following repeated administrations of methamphetamine. Ann. N. Y. Acad. Sci. 801 (1996) 136-147
3. Andersen, J.D., Pouzet, B., 2004. Spatial memory deficits induced by perinatal treatment of rats. Neuropsychopharmacol. 29, 1080-1090.
4. Andersen S.L., Thompson A.T., Rutstein M., Hostetter J.C., and Teicher M.H. Dopamine receptor pruning in prefrontal cortex during the periadolescent period in rats. Synapse 37 (2000) 167-169
5. Balla A., Sershen H., Serra M., Koneru R., and Javitt D.C. Subchronic continuous phencyclidine administration potentiates amphetamine-induced frontal cortex dopamine release. Neuropsychopharmacol. 28 (2003) 34-44
6. Bisagno V., Ferguson D., and Luine V.N. Short toxic methamphetamine schedule impairs object recognition task in male rats. Brain Res. 940 (2002) 95-101
7. Blokland A., Lreben C., and Deuts N.E.P. Anxiogenic and depressive-like effects, but no cognitive deficits, after repeated moderate tryptophan depletion in the rat. J. Psychopharmacol. 16 (2002) 39-49
8. Burns L.H., Annett L., Kelley A.E., Everitt B.J., and Robbins T.W. Effects of lesions to amygdala, ventral subiculum, medial prefrontal cortex, and nucleus accumbens on the reaction to novelty: implication for limbic-striatal interactions. Behav. Neurosci. 110 (1996) 60-73
9. Campbell U.C., Lalwani K., Hernandez L., Kinney G.G., Conn P.J., and Bristow L.J. The mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) potentiates PCP-induced cognitive deficits in rats. Psychopharmacology 175 (2004) 310-318
10. Castellani S., and Adams P.M. Acute and chronic phencyclidine effects on locomotor activity, stereotypy and ataxia in rats. Eur. J. Pharm. 73 (1981) 143-154
11. Clemens K.J., Van Nieuwenhuyzen P.S., Li K.M., Cornish J.L., Hunt G.E., and McGregor I.S. MDMA ("ecstasy"), methamphetamine and their combination: long-term changes in social interaction and neurochemistry in the rat. Psychopharmacology 173 (2004) 318-325
12. Clemens K.J., Cornish J.L., Hunt G.E., and McGregor I.S. Repeated weekly exposure to MDMA, methamphetamine or their combination: long-term behavioural and neurochemical effects in rats. Drug Alcohol. Depend. 86 (2007) 183-190
13. Dalley J.W., Cardinal R.N., and Robbins T.W. Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates. Neurosci. Biobehav. Rev. 28 (2004) 771-784
14. Espejo E.F. Prefrontocortical dopamine loss in rats delays long-term extinction of contextual conditioned fear, and reduces social interaction without affecting social interaction memory. Neuropharmacology 28 (2003) 490-498
15. Farber N.B. The NMDA receptor hypofunction models of psychosis. Ann. N. Y. Acad. Sci. 1003 (2003) 119-130
16. Farber N.B., Wozniak D.F., Price M.T., Labruyere J., Huss J., Peter H.S., and Olney J.W. Age-specific neurotoxicity in the rat associated with NMDA receptor blockade: potential relevance to schizophrenia?. Soc. Biol. Psychiatr. 38 (1995) 788-796
17. Farber N.B., Jian X.P., Heinkel C., and Nemmers B. Antiepileptic drugs and agents that inhibit voltage-gated sodium channels prevent NMDA antagonist neurotoxicity. Mol. Psychiatr. 7 (2002) 726-733
18. Feenstra M.G. Dopamine and noradrenaline release in the prefrontal cortex in relation to unconditioned and conditioned stress and reward. Prog. Brain Res. 126 (2000) 133-163
19. Feenstra M.G., Botterblom M.H., and Mastenbroek S. Dopamine and noradrenaline efflux in the prefrontal cortex in the light and dark period: effects of novelty and handling and comparison to nucleus accumbens. Neuroscience 100 (2000) 741-748
20. File S.E., and Seth P. A review of 25 years of the social interaction test. Eur. J. Pharmacol. 463 (2003) 35-53
21. Fone K.C., Beckett S.R., Topjam I.A., Swerrnham J., Ball M., and Maddocks L. Long-term changes in social interaction and reward following repeated MDMA administration to adolescent rats without accompanying serotonergic neurotoxicity. Psychopharmacology 159 (2002) 437-444
22. Friedman S.D., Castaneda E., and Hodge G.K. Long-term monoamine depletion, differential recovery, and subtle behavioral impairment following methamphetamine-induced neurotoxicity. Pharmacol. Biochem. Behav. 61 (1998) 35-44
23. Fumagalli F., Gainetdinov R.R., Valenzano K.J., and Caron M.G. Role of dopamine transporter in methamphetamine-induced neurotoxicity: evidence from mice lacking the transporter. J. Neurosci. 18 (1998) 4861-4869
24. Gelbard H.A., Teicher M.H., Faedda G., and Baldessarini R.J. Postnatal development of dopamine D1 and D2 receptor sites in rat striatum. Dev. Brain Res. 49 (1989) 123-130
25. Hanania T., Hillman D.R., and Johnson K.M. Augmentation of locomotor activity by chronic phencyclidine is associated with an increase in striatal NMDA receptor function and an upregulation of the NR1 receptor subunit. Synapse 31 (1999) 229-239
26. Hanson G.R., Midgley L.P., Bush L.G., and Gibb J.W. Response of extrapyramidal and limbic neurotensin systems to phencyclidine treatment. Eur. J. Pharmacol. 278 (1995) 167-173
27. Harich S., Gross G., and Bespalov A. Stimulation of the metabotropic glutamate 2/3 receptor attenuates social novelty discrimination deficits induced by neonatal phencyclidine treatment. Psychopharmacology (Berl) 192 (2007) 511-519
28. Harich S., Koch M., and Schwabe K. Effects of repeated dizocilpine treatment on adult rat behavior after neonatal lesions of the entorhinal cortex. Prog. Neuropsychopharmacol. Biol. Psychiatry 32 (2008) 816-827
29. Jacobs P.S., Taylor B.M., and Bardgett M.E. Maturation of locomotor and Fos responses to the NMDA antagonists, PCP and MK-801. Brain Res. Dev. Brain Res. 122 (2000) 91-95
30. Javitt D.C., Balla A., Burch S., Suckow R., Xie S., and Sershen H. Reversal of phencyclidine-induced dopaminergic dysregulation. Psychopharmacology 29 (2004) 300-307
31. Jentsch J.D., and Taylor J.R. Impaired inhibition of conditioned responses produced by subchronic administration of phencyclidine to rats. Psychopharmacology 24 (2001) 66-74
32. Jentsch J.D., Tran A., Taylor J.R., and Roth R.H. Prefrontal cortical involvement in phencyclidine-induced activation of the mesolimbic dopamine system: behavioral and neurochemical evidence. Psychopharmacol. 138 (1998) 89-95
33. Kalsbeek A., Voorn P., Buijs R.M., Pool C.W., and Uylings H.B. Development of the dopaminergic innervation in the prefrontal cortex of the rat. Comp. Neurol. 269 (1988) 58-72
34. Kesner R.P., and Dakis M. Phencyclidine disrupts acquisition and retention performance within a spatial continuous recognition memory task. Pharm. Biochem. Behav. 44 (1993) 419-424
35. Kokoshka J.M., Fleckenstein A.E., Wilkins D.G., and Hanson G.R. Age-dependent differential responses of monoaminergic systems to high doses of methamphetamine. J. Neurochem. 75 (2000) 2095-2102
36. Lanier L.P., and Isaacson R.L. Early developmental changes in the locomotor response to amphetamine and their relation to hippocampal function. Brain Res. 126 (1977) 567-575
37. Legault M., and Wises R.A. Novelty-evoked elevations of nucleus accumbens dopamine: dependence on impulse flow from the ventral subiculum and glutamatergic neurotransmission in the ventral tegmental area. Eur. J. Neurosci. 13 (2001) 819-828
38. Levine J.B., Leeder A.D., Parekkadan B., Berdichevsky Y., Rauch S.L., Smoller J.W., Konradi C., Berthiaume F., and Yarmush M.L. Isolation rearing impairs wound healing and is associated with increased locomotion and decreased immediate early gene expression in the medial prefrontal cortex of juvenile rats. Neuroscience 151 (2008) 589-603
39. Martinez Z.A., Halim N.A., Oostwegel J.L., Gyer M.A., and Swerdllow N.R. Ontogeny of phencyclidine and apomorphine-induced startle gating deficits in rats. Pharm. Biochem. Behav. 65 (2000) 449-457
40. McCullough L.D., and Salamone J.D. Increase in extracellular dopamine levels and locomotor activity after direct infusion of phencyclidine into nucleus accumbens. Brain Res. 577 (1992) 1-9
41. McGregor I.S., Clemens K.J., Van der Plasse G., Li K.M., Hunt G.E., Chen F., and Lawrence A.J. Increased anxiety 3 months after brief exposure to MDMA ("ecstasy") in rats: association with altered 5-HT transporter and receptor density. Neuropsychopharm 28 (2003) 1472-1484
42. Melega W.P., Williams A.E., Schmits D.A., DiStefano E.W., and Cho A.K. Pharmacokinetic and pharmacodynamic analysis of the actions of d-amphetamine and d-methamphetamine on the dopamine terminal. Pharm. Exp. Ther. 274 (1995) 90-96
43. Mori T., Ito S., Kita T., and Sawaguchi T. Effects of dopamine- and serotonin-related compounds on methamphetamine-induced self-injurious behavior in mice. J. Pharmacol. Sci. 96 (2004) 459-464
44. Nishijima K., Kashiwa A., Hashimoto A., Iwama H., Umino A., and Nishikawa T. Differential effects of phencyclidine and methamphetamine on dopamine metabolism in rats frontal cortex and striatum as revealed by in vivo dialysis. Synapse 22 (1996) 304-312
45. Rebec G.V., White I.M., and Puotz J.K. Responses of neurons in dorsal striatum during amphetamine-induced stereotypy. Psychopharmacology 130 (1997) 343-351
46. Rodefer J.S., Murphy E.R., and Baxter M.G. PDE10A inhibition reverses subchronic PCP-induced deficits in attentional set-shifting in rats. Eur. J. Neurosci. 21 (2005) 1070-1076
47. Salazar R.F., White W., Lacroix L., Feldon J., and White I.M. NMDA lesions in the medial prefrontal cortex impair the ability to inhibit responses during reversal of a simple spatial discrimination. Behav. Brain Res. 152 (2004) 413-424
48. Sams-Dodd F. Phencyclidine-induced stereotyped behaviour and social isolation in rats: a possible animal model of schizophrenia. Behav. Pharmacol. 7 (1996) 3-23
49. Sams-Dodd F. Effects of dopamine agonists and antagonists on PCP-induced stereotyped behaviour and social isolation in the rat social interaction test. Psychopharmacology 135 (1998) 182-193
50. Sams-Dodd F. (+) MK-801 and phencyclidine induced neurotoxicity do not cause enduring behaviors resembling the positive and negative symptoms of schizophrenia in the rat. Basic Clin. Pharmacol. Toxicity 95 (2004) 241-246
51. Scalzo F.M. The role of NMDA systems in the developmental neurobehavioral toxicity of phencyclidine. Eur. Neuropsychopharmacol. 6 (1996) 28-29
52. Scalzo F.M., and Burge L.J. The role of NMDA and sigma systems in the behavioral effects of phencyclidine in preweanling rats. Neurotoxicology 15 (1994) 191-200
53. Schroder N., O'dell S.J., and Marshall J.F. Neurotoxic methamphetamine regimen severely impairs recognition memory in rats. Synapse 49 (2003) 89-96
54. Shimada A., Yamaguchi K., and Yanagita T. Neurochemical analysis of the psychotoxicity of methamphetamine and cocaine by microdialysis in the rat brain. N. Y. Acad. Sci. 801 (1996) 361-370
55. Shoblock J.R., Maisonneuve I.M., and Glick S.D. Differences between d-methamphetamine and d-amphetamine in rats: working, tolerance, and extinction. Psychopharmacology 170 (2003) 150-156
56. Sircar R. Postnatal phencyclidine-induced deficit in adult water maze performance is associated with N-methyl-d-aspartate receptor upregulation. Int. J. Dev. Neurosci. 21 (2003) 159-167
57. Sircar R., and Rudy J.W. Repeated neonatal phencyclidine treatment impairs performance of a spatial task in juvenile rats. Ann. N. Y. Acad. Sci. 844 (1998) 303-309
58. Sircar R., and Soliman K.F. Effects of postnatal PCP treatment on locomotor behavioral and striatal D2 receptor. Pharmacol. Biochem. Behav. 74 (2003) 943-952
59. Steinpreis R.E., and Salamone J.D. The role of nucleus accumbens dopamine in the neurochemical and behavioral effects of phencyclidine: a microdialysis and behavioral study. Brain Res. 612 (1993) 263-270
60. Tanii Y., Nishikawa T., Hashimoto A., and Takahashi K. Stereoselective antagonism by enantiomers of alanine and serine of phencyclidine-induced hyperactivity, stereotypy and ataxia in the rat. J. Pharmacol. Exp. Ther. 269 (1994) 1040-1048
61. Timar J., Gyarmati S., Szabo A., and Furst S. Behavioural changes in rats treated with a neurotoxic dose regimen of dextrorotatory amphetamine derivatives. Behav. Pharmacol. 14 (2003) 199-206
62. Tonissaar M., Philips M.A., Eller M., and Harro J. Sociability trait and serotonin metabolism in the rat social interaction test. Neurosci. Lett. 367 (2004) 309-312
63. Tran A.H., Tamura R., Uwano T., Kobayashi T., Katsuki M., and Ono T. Dopamine D1 receptors involved in locomotor activity and accumbens neural responses to prediction of reward associated with place. PNAS 102 (2005) 2117-2122
64. Tucci S., Contreras Q., Paez X., Gonzalez L., Rada P., and Hernandez L. Medial prefrontal transection enhances social interaction II: neurochemical studies. Brain Res. 887 (2000) 259-265
65. Vorhees C.V., Ahrens K.G., Acuff-Smith K.D., Schilling M.A., and Fisher J.E. Methamphetamine exposure during early postnatal development in rats: I. Acoustic startle augmentation and spatial learning deficits. Psychopharmacology 114 (1994) 392-401
66. Vorhees C.V., Ahrens K.G., Acuff-Smith K.D., Schilling M.A., and Fisher J.E. Methamphetamine exposure during early postnatal development in rats: II. Hypoactivity and altered responses to pharmacological challenge. Psychopharmacology 114 (1994) 402-408
67. Vorhees C.V., Reed T.M., Morford L.L., Fukumura M., Wood S.L., Brown C.A., Skelton M.R., McCrea A.E., Rock S.L., and Williams M.T. Periadolescent rats (P41-50) exhibit increased susceptibility to d-methamphetamine-induced long-term spatial and sequential learning deficits compared to juvenile (P21-30 or P31-40) or adult rats (P51-60). Neurotoxicol. Teratol. 27 (2005) 117-134
68. Wang C., McInnis J., Ross-Sanchez M., Shinnick-Gallagher P., Wiley J.L., and Johnson K.M. Long-term behavioral and neurodegenerative effects of perinatal phencyclidine administration: implications for schizophrenia. Neuroscience 107 (2001) 535-550
69. Whishaw I.Q., and Auer R.N. Immediate and long-lasting effects of MK-801 on motor activity, spatial navigation in a swimming pool and EEG in the rat. Psychopharmacology 98 (1989) 500-507
70. White I.M., Flory G.S., Hooper K.C., Speciale J., Banks D.A., and Rebec G.V. Phencyclidine-induced increases in striatal neuron firing in behaving rats: reversal by haloperidol and clozapine. J. Neural. Transm. 102 (1995) 99-112
71. White I.M., Doubles L., and Rebec G.V. Cocaine-induced activation of striatal neurons during focused stereotypy in rats. Brain Res. 810 (1998) 146-152
72. Williams M.T., Morford L.L., Wood S.L., Wallace T.L., Fukumura M., Broening H.W., and Vorhees. Developmental d-methamphetamine treatment selectively induces spatial navigation impairments in reference memory in the Morris water maze while sparing working memory. Synapse 48 (2003) 138-148
73. Williams M.T., Moran M.S., and Vorhees C.V. Refining the critical period for methamphetamine-induced spatial deficits in the Morris water maze. Psychopharmacology 168 (2003) 329-338
74. Zhang H., Kiyatkin E.A., and Stein E.A. Behavioral and pharmacological modulation of ventral tegmental dendritic dopamine release. Brain Res. 656 (1994) 59-70
75. Zhu J.P.Q., Xu W., Angulo N., and Angulo J.A. Methamphetamine-induced striatal apoptosis in the mouse brain: comparison of a binge to an acute bolus drug administration. Neurotoxicol 27 (2005) 131-136
76. Zhu J.P.Q., Xu W., and Angulo J.A. Disparity in the temporal appearance of methamphetamine-induced apoptosis and depletion of dopamine terminal markers in the striatum of mice. Brain Res. 1049 (2005) 171-181
77. Zukin S.R., and Javitt D.C. Phencyclidine receptor binding as a probe of NMDA receptor functioning: implications for drug abuse research. NIDA Res. Monogr. 133 (1993) 1-12